Is GLAXO a Buy? GLAXO Smart-Money Analysis, Fair Value & Signal

ZEME verdict — Watching phase

Neutral — no decisive smart-money signal yet; better setups may exist.

What ZEME decides about GLAXO, and why

TRIM — earned weight 0 of 1.00, the summed measured record of the backing engines.

Because. 25% above fair value

Risk. stop 302.68 (2.9% below close) — exit there

The case against. against: 25% above fair value

What happens next after the Watching phase

Measured from 582 completed Watching runs in ZEME's recorded phase history — these are frequencies of what actually happened next, not forecasts:

EARLY LOAD — 66.3% of the time (n=386)
LAUNCHING — 10.7% of the time (n=62)
FULLY LOADED — 8.4% of the time (n=49)
EXITED — 5.0% of the time (n=29)
RUNNING — 3.6% of the time (n=21)
WATCH_ONLY — 3.1% of the time (n=18)
LOADING — 1.5% of the time (n=9)
DISTRIBUTING — 1.4% of the time (n=8)

Typical stay in this phase: 4 sessions (median). measured from 2026-07-16

ZEME publishes the case against its own signals, and the base rate any share has to beat. Educational analysis, not investment advice.

Price	Rs 312.45
ZEME fair value	Rs 234.38
Discount to fair value	-25.0%
Smart-money phase	Watching
Confidence score	32/100
RSI (14)	43.8
P/E	9.6
ROE	32.7%
Dividend yield	6.1%
52-week range	Rs 293.08 – Rs 459.27
Sector	Pharmaceuticals
Shariah-compliant	Yes ☪

✅ Get GLAXO signals free — create your ZEME account 📈 Live interactive chart & signals 💬 Ask ZEME about GLAXO

GLAXO (GlaxoSmithKline Pakistan Limited) trades at Rs 312.45 on the Pakistan Stock Exchange, in the Watching smart-money phase — neutral. ZEME's model puts fair value near Rs 234.38, making it about 25.0% overvalued. No decisive smart-money footprint yet — one to watch, not chase.

ZEME AI reads GLAXO through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.

Is GLAXO a buy right now?

Neutral — no decisive smart-money signal yet; better setups may exist. No decisive smart-money footprint yet — one to watch, not chase. As of 16 Oct 2026, GLAXO is in the Watching phase with a ZEME confidence score of 32/100.

What is GLAXO's fair value?

ZEME estimates GLAXO's fair value at about Rs 234.38, versus a market price of Rs 312.45 — roughly 25.0% overvalued.

What smart-money phase is GLAXO in?

GLAXO is currently in the Watching phase. No decisive smart-money footprint yet — one to watch, not chase.

More Pharmaceuticals stocks Fundamentals Dividend blue-chips ✓ Track record

Data updated 16 Oct 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.